This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okudela, K. Articles by Kitamura, H. Search for Related Content PubMed PubMed Citation Articles by Okudela, K. Articles by Kitamura, H.

(American Journal of Pathology. 2004;164:91-100.)
© 2004 American Society for Investigative Pathology

K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation

Possible Contribution to Non-Invasive Expansion of Lung Adenocarcinoma

Koji Okudela^*, Hiroyuki Hayashi, Takaaki Ito^*, Takuya Yazawa^*, Takehisa Suzuki^*, Yuko Nakane^*, Hanako Sato^*, Haruhiko Ishi^*, Xin KeQin, Akira Masuda, Takashi Takahashi and Hitoshi Kitamura^*

From the Departments of Pathology^* and Bacteriology, Yokohama City University School of Medicine, Yokohama; the Division of Pathology, Kanagawa Cancer Center Hospital, Yokohama; and the Laboratory of Ultrastrcture Research, Aichi Cancer Center Research Institute, Division of Molecular Oncology, Nagoya, Japan

Point mutations of the K-ras gene, which are found in 10 to 30% of lung adenocarcinomas, are regarded as being an early event during the carcinogenesis. Autonomous vigorous motility of neoplastic cells, as well as growth and survival advantages, are considered to be necessary for cancer development and progression. The present study describes the contributions of the K-ras gene mutation and its downstream pathway via phosphatidylinositol 3-OH kinase (PI3K)-Akt to the cell motility in an immortalized human peripheral airway epithelial cell (HPL1D) and lung adenocarcinoma cells (A549, H820, TKB6, and TKB14). We have also evaluated the relationship between pathological events and the K-ras-Akt pathway using surgically resected lung tumors. The HPL1D cells transfected with the mutated K-ras gene (HPL-V12) showed a significant increase in cell motility compared to those transfected with empty vector (HPL-E) or wild-type K-ras gene (HPL-K). The enhanced motility in the HPL-V12 cells was markedly reduced by either treatment with inhibitors of ras, PI3K, and/or MEK, or by transfection with the dominant-negative mutant Akt (dnAkt). The lung adenocarcinoma cells bearing the K-ras gene mutation (A549 and H820) showed consistently higher levels of cell motilities than those without the mutation (TKB6 and TKB14), and the motility of A549 and H820 cells were significantly inhibited by dnAkt transfection. These results suggest that the K-ras gene mutation could enhance the motility of neoplastic cells through a pathway involving PI3K-Akt. Actually, among the surgically resected lung tumors, the adenocarcinomas with the K-ras gene mutation tended to show a higher frequency and intensity of immunoreactivity for phosphorylated Akt (p-ser473Akt) than those without the mutation, supporting the in vitro observation that the mutated K-ras can activate the PI3K-Akt pathway. Immunoreactivity for p-ser473Akt was also seen in the pre-malignant and early lesions at a frequency similar to that in the advanced lung adenocarcinomas,. No correlation was seen between p-ser473Akt immunoreactivity and lymphatic/organ metastasis or prognosis. These results taken together suggest that the K-ras-Akt pathway might facilitate the motility of neoplastic cells during the early period of carcinogenesis in lung adenocarcinomas, and may contribute to their non-invasive expansion along the alveolar septa, rather than invasion or metastasis.

This article has been cited by other articles:

				C.-X. Xu, D. Jere, H. Jin, S.-H. Chang, Y.-S. Chung, J.-Y. Shin, J.-E. Kim, S.-J. Park, Y.-H. Lee, C.-H. Chae, et al. Poly(ester amine)-mediated, Aerosol-delivered Akt1 Small Interfering RNA Suppresses Lung Tumorigenesis Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 60 - 73. [Abstract] [Full Text] [PDF]

				A. Edwards, J. Li, P. Atadja, K. Bhalla, and E. B. Haura Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor dependent human lung cancer cells Mol. Cancer Ther., September 1, 2007; 6(9): 2515 - 2524. [Abstract] [Full Text] [PDF]

				H. Sato, T. Yazawa, T. Suzuki, H. Shimoyamada, K. Okudela, M. Ikeda, K. Hamada, H. Yamada-Okabe, M. Yao, Y. Kubota, et al. Growth Regulation via Insulin-Like Growth Factor Binding Protein-4 and -2 in Association with Mutant K-ras in Lung Epithelia Am. J. Pathol., November 1, 2006; 169(5): 1550 - 1566. [Abstract] [Full Text] [PDF]

				S. M Dougherty, W. Mazhawidza, A. R Bohn, K. A Robinson, K. A Mattingly, K. A Blankenship, M. O Huff, W. G McGregor, and C. M Klinge Gender difference in the activity but not expression of estrogen receptors {alpha} and {beta} in human lung adenocarcinoma cells. Endocr. Relat. Cancer, March 1, 2006; 13(1): 113 - 134. [Abstract] [Full Text] [PDF]

				J. Grimm, D. G. Kirsch, S. D. Windsor, C. F. B. Kim, P. M. Santiago, V. Ntziachristos, T. Jacks, and R. Weissleder Use of gene expression profiling to direct in vivo molecular imaging of lung cancer PNAS, October 4, 2005; 102(40): 14404 - 14409. [Abstract] [Full Text] [PDF]

				H. W. Kim, I. K. Park, C. S. Cho, K. H. Lee, G. R. Beck Jr., N. H. Colburn, and M. H. Cho Aerosol Delivery of Glucosylated Polyethylenimine/Phosphatase and Tensin Homologue Deleted on Chromosome 10 Complex Suppresses Akt Downstream Pathways in the Lung of K-ras Null Mice Cancer Res., November 1, 2004; 64(21): 7971 - 7976. [Abstract] [Full Text] [PDF]

				O. David, J. Jett, H. LeBeau, G. Dy, J. Hughes, M. Friedman, and A. R. Brody Phospho-Akt Overexpression in Non-Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage Clin. Cancer Res., October 15, 2004; 10(20): 6865 - 6871. [Abstract] [Full Text] [PDF]